37.90 0.00 (0.00%)
After hours: 4:07PM EDT
|Bid||29.99 x 900|
|Ask||38.12 x 1300|
|Day's Range||37.76 - 38.65|
|52 Week Range||26.10 - 40.25|
|Beta (3Y Monthly)||1.77|
|PE Ratio (TTM)||33.25|
|Earnings Date||May 1, 2019 - May 6, 2019|
|Forward Dividend & Yield||0.16 (0.42%)|
|1y Target Est||39.64|
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]
Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Bruker Corporation (NASDAQ:BRKR) with a market-capitalization of US$6.2b, rarely draw their attention. However, history shows that overl...
- Reference library expansion for broader species identification by MALDI Biotyper (MBT) - Increased speed for high-throughput projects by multi-threading MBT HT software (RUO) - Increased microbial ID ...
Bruker Corp NASDAQ/NGS:BRKRView full report here! Summary * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for BRKR with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting BRKR. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $1.31 billion over the last one-month into ETFs that hold BRKR are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
ASILOMAR, Calif., April 8, 2019 /PRNewswire/ -- At the 60th Experimental Nuclear Magnetic Resonance Conference (ENC, www.enc-conference.org ), Bruker announced today a breakthrough in ultra-high field (UHF) high-resolution NMR spectroscopy applied to structural biology and the study of functional intrinsically disordered proteins (IDPs). UHF NMR is complementary to other structural biology methods like X-ray crystallography or cryo-EM by providing structurally-resolved molecular dynamics, as well as functional folding, interactome and drug binding information in solution and at physiological conditions. Bruker has successfully energized the world's first stable and homogeneous standard-bore Ascend 1.1 GHz NMR magnet in late 2018.
Scientific instrument maker BRUKER Corporation (NASDAQ: BRKR ) announced Wednesday that it purchased RAVE LLC's semiconductor mask repair and cleaning business. What Happened Billerica, Massachusetts-based ...
BILLERICA, Mass. , April 3, 2019 /PRNewswire/ -- Bruker Corporation today announced that it has acquired the semiconductor mask repair and cleaning business of RAVE LLC, a leading provider of nanomachining ...
Bruker (BRKR) is progressing well with its three strategic buyouts, indicative of a majority interest in both Hain Diagnostics and Mestrelab along with the Alicona Imaging acquisition.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Bruker Corporation's (NASDAQ:BRKR) most recent earnings announcement in December 2018Read More...
New capabilities of timsTOF Pro introduced at EuPA 2019: - DIA-PASEF work-in-progress with excellent peptide and protein ID performance - New workflows for intact protein analysis in biopharma on timsTOF ...
- Expanded FluoroType™ MTBDR 2.0 Liquid Array molecular assay with CE-IVD mark provides highly differentiated tuberculosis (TB) detection and antibiotic resistance testing - Novel FluoroCycler™ XT PCR ...
PHILADELPHIA , March 18, 2019 /PRNewswire/ -- At Pittcon 2019, Bruker (Nasdaq: BRKR) this week highlights new and innovative analytical systems and high-value applied market solutions for food analysis, ...
Enhanced Focus on Pharma and Biopharma Software and Workflow Solutions BILLERICA, Mass. , March 14, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) today announced that it has acquired Arxspan LLC, ...